Corresponding Author: Peter Anderyas, MBBS, St Vincent’s Hospital Melbourne, 41 Victoria Parade, Fitzroy, VIC 3065, Australia (firstname.lastname@example.org).
Published Online: October 24, 2022. doi:10.1001/jamaneurol.2022.3479
Conflict of Interest Disclosures: None reported.
Additional Contributions: We thank the patient for granting permission to publish this information. We also acknowledge and thank Penny McKelvie, MBBS (St Vincent’s Hospital Melbourne), for providing pathology images and interpretation; compensation was not received.
NMB , Klein
CJ , Waters
P , Pittock
SJ , Irani
SR . LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes. J Neurol Neurosurg Psychiatry
. 2018;89(5):526-534. doi:10.1136/jnnp-2017-315720Google ScholarCrossref
SR , Alexander
S , Waters
et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain
. 2010;133(9):2734-2748. doi:10.1093/brain/awq213PubMedGoogle ScholarCrossref